NCT00254969View on ClinicalTrials.gov

Immunogenicity and Safety of Pentaxim in South African Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

January 31, 2010

Conditions
DiphtheriaTetanusHaemophilus InfectionsPertussisPoliomyelitis
Interventions
BIOLOGICAL

Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib

0.5 mL, Im

Trial Locations (1)

Unknown

Soweto

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY